Stem Cell Leukemia Recruiting Phase 3 Trials for Nalbuphine (DB00844)

IndicationStatusPhase
DBCOND0117311 (Stem Cell Leukemia)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03825887Nalbuphine Versus Morphine for Mucositis Pain in Pediatric Cancer PatientsPrevention